J. Scott Garland

ELVN

J. Scott Garland serves as director at Enliven Therapeutics, Inc. (ELVN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$606.7K

Net Position

Net Seller

$606.7K

Companies Traded

ELVN

Active Period

Oct 2026

1 total trades

Most Recent

Sell ELVN

Oct 5, 2026 · $606.7K

J. Scott Garland's Insider Trading at Enliven Therapeutics, Inc. (ELVN)

Buys

0 · $0.00

Sells

1 · $606.7K

Total Shares Bought

Total Shares Sold

13,000

ELVN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 5, 2026	Sell	13,000	$46.67	$606.7K	0

Related Insiders

Benjamin Hohl

officer: CHIEF FINANCIAL OFFICER

ELVNSell · Oct 21, 2026

Helen Louise Collins

officer: CHIEF MEDICAL OFFICER

ELVNSell · Oct 21, 2026

Mika K Derynck

director

ELVNSell · Aug 6, 2026

Lori Anne Kunkel

director

ELVNSell · Jul 8, 2026

ORBIMED ADVISORS LLC

10 percent owner

ELVNSell · Jun 24, 2026

Richard A. Heyman

Director

ELVNSell · Feb 19, 2026

Joseph P Lyssikatos

officer: CHIEF SCIENTIFIC OFFICER

ELVNSell · Feb 10, 2026

Anish Patel

officer: CHIEF OPERATING OFFICER

ELVNSell · Jan 13, 2026

Explore More Insider Trading Data

ELVN Insider Trading Activity

View all insider trades at Enliven Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity